Algernon Pharmaceuticals Inc (AGNPF)

[Money $hot]

I basically disagree with everything you said.

What I posted is evidence of an EOP2 meeting happening within 30 days.

I don't believe anyone is disputing a meeting will happen within 70 days as described by AP - an obvious outcome.

You simply missed the point of my post.

As to what many companies don't discuss as far as "up-coming" FDA meetings....yeah I think I made that clear already.

Thanks for reiterating the same.

What do you consider a "surprise" of an early date for EOP2?

You seem to suggest anything less than 70 days is a surprise?

As to the IPF/CC study...I've previously made the same argument about scrapping the study.

However, I haven't gone off on the deep end about completely scrapping the NUMBER ONE lead candidate in the pipeline.

IF Algernon doesn't believe Ifenprodil has any positive effect based on management having received preliminary data already (wouldn't doubt it) for its 5 PATIENTS thus far, then yeah kill the deal.

Otherwise, my thought on the matter was scrap it and relaunch it elsewhere other than AU/NZ which has become the dumbest out the gate study a CEO could accomplish.

AP is just about the unluckiest or incompetent biotech out there when it comes to executing it's timelines to data.

It's my belief a slow roll to data was part of the plan all along for IPF/CC.

It was pigeonholed by design.

You'll never convince me otherwise that management/directors/Novotech wasn't wise enough to know what the terrain looked like in AU/NZ for recruitment of IPF/CC patients.

That's a pretty big collection of incompetence were paying for in spades (AP dug a gigantic hole) in AU/NZ.

Delay after delay of enrollment for the COVID trial/study or what the f ever you wanna call it, pushed the timeline to a point where a fire halfway around the world in a 2nd World country damn near wiped out AP for this entire year getting to any data for a trial/study.

The CEO says folks should support the story if they like it.

SMH...Just Crazy Sh!t.

Meanwhile, the CEO continues to hand over the company to PP folks with dirt cheap shares.

It's a nonstop bleed of common shareholder ownership unless and until AP actually proves it has data the real world can use/monetize.

As shareholders we are dealing with multiple headwinds at AP.

Team Cobra being at the center of all the turmoil.

The same as EVERY company King Cobra touches with the exception of Cannabix and even in that situation AP got royally screwed by the CEO and Directors.

All other companies in his grip goes through massive dilution, name changes, and drama beyond reason.

The same sh!t that Christopher Moreau has brought to bear at AP.

As I've stated before, IF the CEO comes away from the EOP2 meeting with nothing other than the blessing of the FDA to move forward with a Ph3 study/trial (or whatever the CEO wants to call it moving forward) we are royally F'd again.

The CEO has nothing up his sleeve form what I can tell beyond a Ph3 other than stories about DMT prior to a Ph1 thus fr scheduled for the end of this year.

The CEO F'd us good with his "SUPER cost effective" strategy for the NUMBER ONE lead study coming out of AP back in July 2020.

Meanwhile....have at it.

M$